Published: Sep 20th, 2018
The Woods Lab is searching for a highly qualified post-doctoral associate candidate to join the research team of to study the benefits of transcranial direct current stimulation (tDCS) for enhancing […]
Published: Sep 18th, 2018
The portion of the US population 65 years and older is rapidly increasing, with the population of 65+ older adults expected to double by 2050. In turn, the number of […]
Published: Sep 18th, 2018
Transcranial near-infrared (NIR) photobiomodulation is a method of non-invasive brain stimulation that uses light in the near-infrared spectrum to the scalp to stimulate underlying brain tissue. This method applies small […]
Published: Sep 18th, 2018
The Efficient Brain Study is an industry funded Phase II clinical trial investigating the impact of Fermented Papaya Product (FPP) on brain mitochondrial function, neuroinflammation, and cognitive function in older […]
Published: Sep 18th, 2018
Associate Professor and Assistant Director Dr. Adam J. Woods Post-Doctoral Fellow, Cognitive Neuroscience, University of Pennsylvania, Philadelphia, PA PhD, Cognitive Neuroscience, George Washington University, Washington, DC BS, Psychology, University of […]
Published: Sep 18th, 2018
Adam J. Woods, Ph.D. Associate Professor and Assistant Director Dr. Adam J. Woods Post-Doctoral Fellow, Cognitive Neuroscience, University of Pennsylvania, Philadelphia, PA PhD, Cognitive Neuroscience, George Washington University, Washington, DC […]
Published: Sep 18th, 2018
Neuromodulation Textbooks Knotkova H, Bikson M, Nitsche M, Woods AJ. 2019. Practical Guide to Transcranial Direct Current Stimulation. Springer New York Peer Reviewed Im J, Jeong H, Bikson M, Woods AJ, Unal […]
Published: Sep 18th, 2018
The Stimulated Brain Study is a Phase II randomized dose response clinical trial funded by the National Institute on Aging. The Stimulated Brain study investigates the effects of different transcranial […]
Published: Sep 18th, 2018
The Augmenting Cognitive Training in Older Adults (ACT Study) is a Phase III definitive multi-site randomized clinical trial with an adaptive design that will establish the benefit of delivering adjunctive […]
